This trial will use a device to record electrical activity in the brain to detect patterns associated with PTSD, which will then be treated with electrical pulses in an attempt to improve symptoms.
7 Primary · 25 Secondary · Reporting Duration: quarterly during year 2-4
6 Total Participants · 1 Treatment Group
Primary Treatment: NeuroPace® RNS® System · No Placebo Group · Phase < 1
Age 25 - 60 · Male Participants · 10 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
|18 - 65||100.0%|
|VA Greater Los Angeles||100.0%|